The pedunculopontine nucleus (PPN) is a part of the reticular activating system and one of the main sources of the cholinergic fibers in the midbrain, while it is also subject to cholinergic modulation. This nucleus is known to be a structure that controls sleep-wake cycles, arousal, and locomotion. Neurons of the PPN are targets of several neuromodulatory mechanisms, which elicit heterogeneous pharmacological responses including hyperpolarization and depolarization, whereas lack of response can also be observed. In agreement with previous findings, we found that PPN neurons respond to the muscarinic agonist carbachol in a heterogeneous manner: they were depolarized and showed increased firing rate, decreased firing frequency, and were hyperpolarized, or showed no response. The heterogeneity of the muscarinic activation was similar to our previous observations with type 1 cannabinoid (CB1) receptor agonists; therefore, we investigated whether muscarinic and endocannabinoid modulatory mechanisms elicit the same action on a certain neuron. To achieve this, whole-cell patch clamp experiments were conducted on midbrain slices containing the PPN. Carbachol was applied first and, after recording the changes in the membrane potential and the firing frequency and achieving washout, the CB1 receptor agonist arachidonyl-2′-chloroethylamide (ACEA) was applied. A marked but not full overlap was observed: all neurons depolarized by carbachol were depolarized by the CB1 receptor agonist ACEA, and all neurons lacking response to carbachol lacked response to ACEA as well. However, neurons hyperpolarized by carbachol were depolarized, hyperpolarized, or not affected by the ACEA. These results indicate that endocannabinoid and muscarinic modulatory effects involve similar mechanisms of action. NeuroReport 26:273-278
Introduction
The pedunculopontine nucleus (PPN) is a part of the reticular activating system and, together with the laterodorsal tegmental nucleus, is the main source of the cholinergic fibers in the midbrain. The nucleus makes an important contribution toward the sleep-wake cycles, arousal, and locomotion. Besides the cholinergic neurons, the nucleus is also composed of noncholinergic cells, which are mostly GABAergic and glutamatergic [1, 2] .
The PPN not only provides cholinergic neuromodulation for several brain areas but is also a target of neuromodulatory mechanisms. Muscarinic and nicotinic cholinergic [3] [4] [5] serotonergic [6, 7] , and GABAergic [8] effects have already been described, as well as modulatory effects by orexin, ghrelin [9] , or endocannabinoids [10, 11] . These effects overlap in certain cases: neurons hyperpolarized by serotonin are hyperpolarized by the stimulation of muscarinic acetylcholine receptors as well [6] , and orexin and ghrelin depolarize the same neuronal population [9] .
The PPN receives cholinergic fibers from the laterodorsal tegmental nucleus and the contralateral PPN [4, 12] . Acetylcholine causes neuronal hyperpolarization by activating inward rectifier potassium current through M2 and M4 muscarinic receptors [4, 6] . Activation of M1 muscarinic or nicotinic acetylcholine receptor (nAChR) led to the activation of an inward current, whereas a smaller proportion of neurons showed a biphasic response or did not respond to cholinergic stimulation [4] .
According to our recent observations on midbrain slices, activation of the CB1 receptor can depolarize or hyperpolarize neurons eliciting inward and outward currents, whereas a smaller population of neurons lacks response. These effects are largely because of activation and glutamate release of astrocytes, which, in turn, activate different subgroups of metabotropic glutamate receptors [11] . The effects of CB1 receptor stimulation resembled the ones elicited by carbachol, where neurons responded with inward or outward currents or lacked response [4] .
Although cholinergic and endocannabinoid neuromodulatory mechanisms elicit almost identical effects of the PPN neurons, it has not yet been investigated whether these effects activate the same or different populations of neurons. To achieve this, whole-cell patch clamp experiments were conducted on midbrain slices containing the PPN, and the changes in the resting membrane potential and firing rate were compared in the presence of carbachol and arachidonyl-2′-chloroethylamide (ACEA). These drugs depolarized the same neuronal population, and neurons lacking a response to carbachol did not respond to ACEA as well. However, neurons hyperpolarized by muscarinic stimulation responded to the cannabinoid agonist with depolarization and hyperpolarization, or lacked a response.
Materials and methods

Solutions, chemicals
Experiments were conducted in an artificial cerebrospinal fluid (aCSF) with the following composition (in mM): NaCl, 125; KCl, 2.5; NaHCO 3 , 26; and glucose, 10; NaH 2 PO 4 , 1.25; CaCl 2 , 2; MgCl 2 , 1; myo-inositol, 3; ascorbic acid, 0.5; and sodium-pyruvate, 2. For the slice preparation, 100 mM NaCl was replaced by sucrose (130 mM) and glycerol (60 mM; low Na aCSF). All chemicals were purchased from Sigma (St Louis, Missouri, USA), unless otherwise stated.
Animals, preparation
Animal experiments were conducted in accordance with the appropriate international and Hungarian laws and institutional guidelines on the care of research animals. The experimental protocols were approved by the Committee of Animal Research of the University of Debrecen. C3H mice of age 9-13 days were used (n = 16). The animals were subjected to the lowest possible levels of pain and discomfort.
Electrophysiology
After decapitation of the animal and removal of the brain, 200 μm-thick coronal midbrain slices were prepared in ice-cold low Na aCSF using a Microm HM 650V vibratome (Microm International GmbH, Walldorf, Germany). Brain slices were visualized using a Zeiss Axioskop microscope (Carl Zeiss AG, Oberkochen, Germany). Patch pipettes with 5 MΩ pipette resistance were fabricated and filled with a solution containing (in mM) K-gluconate, 120; NaCl, 5; 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 10; EGTA, 2; CaCl 2 , 0.1; Mg-ATP, 5; Na 3 -GTP, 0.3; Na 2 -phosphocreatinine, 10; and biocytin, 8. Whole-cell patch-clamp recordings were performed using an Axopatch 200A amplifier (Molecular Devices, Union City, California, USA). The muscarinic agonist carbamylcholine chloride (carbachol) was used at a 50 μM concentration, whereas ACEA, a CB1 receptor agonist, was administered at 5 μM concentration. Data acquisition was carried out using the Clampex 10.0 software (Molecular Devices), whereas data analysis was carried out using the Clampfit 10.0 (Molecular Devices) and MiniAnalysis (Synaptosoft, Decatur, Georgia, USA) programs. To compare the membrane potentials, a 120-second-long trace segment was selected from the control period and another starting at 3 min after the beginning of drug administration or after 10 min of washout with the control solution. Histograms of the membrane potential values were constructed from these periods and the value corresponding to the largest bin was considered the resting membrane potential [11] .
Membrane potential changes within 2 mV and firing rate changes within 0.5 Hz were considered spontaneous fluctuations, and only changes exceeding this cutoff value were considered depolarization or hyperpolarization [11] .
Statistical analysis
All data are represented as mean SEM. To compare the mean of two independent data sets, Student's t-test was used. In cases where the magnitude of effects caused by the application of carbachol or ACEA was compared, neurons were grouped according to the changes (depolarized, hyperpolarized, and lack of change, 2 mV or 0.5 Hz cutoff) and Fisher's exact test was used with Bonferroni correction of the P values obtained when pairwise comparisons were performed. Calculations were carried out using the statistical module SigmaPlot 12 (Systat Software, San Jose, California, USA) and GraphPad Prism 6 (GraphPad Software, La Jolla, California, USA). The level of significance was P less than 0.05.
To compare the effects of carbachol and ACEA on changes in the membrane potential and firing frequency of the same neurons, data points of Fig. 2d were fit using least-squares linear correlation with OriginPro 8 software (OriginLab Corporations, Northampton, Massachusetts, USA), and R 2 values indicating the validity of a linear fit were applied.
Visualization of the labeled neurons
The neurons were filled with biocytin during the electrophysiological recordings. The slices accommodating the filled neurons were fixed overnight (4% paraformaldehyde in 0.1 M phosphate buffer; pH 7.4; 4°C). Permeabilization was achieved in Tris-buffered saline (in mM, Tris base, 8; Trisma HCl, 42; NaCl, 150; pH 7.4) supplemented with 0.1% Triton X-100 and 10% bovine serum (60 min). The slices were incubated in phosphate buffer containing streptavidin-conjugated Alexa488 (1 : 300; Molecular Probes Inc., Eugene, Oregon, USA) for 90 min. The cells were visualized using a Zeiss LSM 510 confocal microscope (Carl Zeiss AG).
Cholinergic cells were identified with anticholine acetyltransferase labeling (1 : 75; AB114P; Millipore, Temecula, California, USA) and Texas Red rabbit-antigoat secondary antibody (1 : 1000; TI-5000; Vector Laboratories Inc., Burlingame, California, USA).
Results
Whole-cell patch-clamp recordings were performed to characterize the effects of cholinergic stimulation on the membrane potential and the firing pattern of the PPN neurons. To achieve this, 22 PPN neurons were patched. All cells were located dorsally from the superior cerebellar peduncle in its vicinity (within 100 μm) and medially from the lateral lemniscus, both from the pars compacta and the pars dissipata. The majority of the neurons (19 out of 22) fired action potentials spontaneously at a rate of 3.4 0.6 Hz. The average resting membrane potential was − 53.7 0.9 mV. Cells responded to 50 μM carbachol in different ways: 10 (45%) were depolarized with an increase in action potential firing frequency and 7 (32%) were hyperpolarized and decreased firing frequency or completely stopped activity. The rest of the cells [5 (23%)] did not respond to carbachol (Fig. 1a-f ). The magnitude of these changes significantly exceeded the changes of these parameters by spontaneous fluctuations (P = 0.0005 for the resting membrane potential and P = 0.0064 for the firing rate; Fisher's exact test; Fig. 1g ). Neuronal location and morphology was determined by post-hoc reconstruction [11] . Both cholinergic and noncholinergic neurons identified responded to carbachol in a heterogeneous manner as depolarization, lack of response, and hyperpolarization were observed. The heterogeneity of the response to carbachol did not differ significantly from our previous observations with ACEA (P = 0.885 for the resting membrane potential and P = 0.11 for the frequency; Fisher's exact test; Fig. 1h ; [11] ). The average depolarization by carbachol was 4.7 0.45 mV, with a 1.55 0.39 Hz increase in firing frequency. The average hyperpolarization was − 6.58 1.2 mV, and the firing frequency decreased by − 2.8 1.14 Hz.
Because of these overlaps between responses elicited by ACEA and carbachol, we next investigated whether the responses to the cholinergic and cannabinoid stimulations affect the same or different neurons in the same manner. To determine this, whole-cell patch-clamp experiments were conducted again on 16 PPN neurons, where carbachol was first applied and, after achieving good recovery from the effects of carbachol (or washing out carbachol for a similar duration when effects were not observed), 5 μM ACEA, a CB1 receptor agonist, was applied.
In seven cases, carbachol caused depolarization. On these neurons, application of ACEA resulted in depolarization as well (5 0.6 mV for carbachol and 3.8 0.38 mV to ACEA). No significant difference was found in the magnitude of depolarization caused by the two drugs (P = 0.053). In four cases, carbachol did not result in any change; on these cells, ACEA application was ineffective in the same manner. Five neurons were hyperpolarized by carbachol. On these cells, application of ACEA did not show a correlation with this effect, showing a significant difference from the effect of carbachol: one of these cells was depolarized, one was hyperpolarized, and three did not respond to ACEA (in average, − 7.7 1.9 mV for carbachol and 0.48 2.1 mV for ACEA). The difference between the effects of the drugs was found to be significant in this population (P = 0.009). To further evaluate the differences in the effects of carbachol and ACEA on the same populations, the data set in which the membrane potential change to carbachol was plotted against the membrane potential change to ACEA was fitted with a linear function. It was hypothesized that linear fit can be best applied if changes to the drugs used have the same direction and magnitude. When all data points were fit, the R 2 value obtained was 0.086. However, when these values were arbitrarily removed from the data set where carbachol caused hyperpolarization and ACEA caused depolarization or no change, the R 2 value increased markedly (0.801), indicating that there are differences between the effects of the two drugs in only some of those cases when carbachol caused hyperpolarization. Changes in the firing frequency showed similar tendencies. Cells that showed an increase in the firing frequency with carbachol responded to ACEA in a similar manner ( Table 1 ). When linear fit of the data set of firing frequency changes was applied with a similar arrangement as with the resting membrane potential, the R 2 value of all data was − 0.07, whereas when data points of the same neurons were removed similar to when the changes in the membrane potentials were compared, the R 2 value increased to 0.416.
Discussion
We found that neurons of the PPN respond to carbachol (muscarinic agonist) and ACEA (CB1 receptor agonist) in an overlapping manner. Thus, cannabinoid and cholinergic effects have similar overlaps similar to the previously described similarities of cholinergic and serotonergic neuromodulation [6] , or the effects of orexin and ghrelin [9] , indicating that common neuromodulatory pathways might exist in the PPN.
The PPN is composed by heterogeneously reacting cholinergic and noncholinergic cells. This heterogeneity can be a result of several functional and morphological features of PPN neurons. Depending on the behavioral state, certain cells are active only during REM sleep (REM-on), wakefulness (Wake-on), or both wakefulness and REM sleep (Wake-REM-on) [13, 14] . With the use of serotonin, 'REM-on' neurons were suppressed, whereas 'Wake/REM-on' cells were not affected [7, 15] . The heterogeneous behavior of the PPN neurons was found in correlation with the neuronal activity in parallel with global brain states and the synthesized neurotransmitter. Most of the cholinergic neurons increase the firing rate in time with cortical gamma activity, whereas noncholinergic neurons can increase or decrease the firing rate at cortical gamma activity, or fire independent of it [12, 16] . The proportion of hyperpolarization and depolarization by carbachol showed marked differences between cholinergic and noncholinergic neurons [4] . Depolarization by ACEA was dominant in the GABAergic neuronal population, whereas only one-third of cholinergic cells were depolarized [11] .
Heterogeneity of activity patterns of PPN neurons might also depend on neuronal projections. The proportion of neurons responding to carbachol with depolarization or hyperpolarization in this study was different from the responses of a population selected because of their thalamic projection [4] . Neurons in functional subgroups with different responses to global brain states also differ in projection patterns [12, 16, 17] .
Similar to the effect of carbachol, PPN neurons responded to ACEA with depolarization and increased firing rate, hyperpolarization, and decreased firing rate, or did not respond [11] . On those cells that were depolarized by carbachol, ACEA exerted the same depolarizing effect. It was shown that the postsynaptic excitatory effect of carbachol on the PPN thalamic projecting neurons takes place by stimulation of M1 and nAChR [4] . nAChR is considered to be inhibited directly by endocannabinoids independent of CB1 or CB2 receptor activation [18] ; therefore, the involvement of nicotinic receptors in the overlapping depolarizing effect of carbachol and ACEA seems to be unlikely. M1 receptor activation might activate similar mechanisms as CB1 receptor activation, and this might explain the similarity of the effect. A similar overlap between M3 and CB1 receptors by activation of rho-kinase and protein kinase C was described on ciliary muscles [19] .
Astrocytic CB1 receptor activation can depolarize PPN neurons by stimulating astrocytic glutamate release and the resulting activation of likely neuronal group II metabotropic glutamate receptors [11] . As an alternative to the activation of signaling pathways shared by M1 and CB1 receptors, group II mGluRs and M1 receptors can activate or inhibit similar conductances, and this might lead to depolarization of the same neuron.
Activation of muscarinic receptors can stimulate endocannabinoid synthesis as was shown on cerebellar Purkinje-cells [20] and in the hippocampus [9] . If this is the case in the PPN, activation of the M1 receptor increases endocannabinoid synthesis on neurons possessing it, and, in turn, this endocannabinoid acts on astrocytes [11] . Neurons lacking response to carbachol did not respond to ACEA as well. It was shown that nonresponding cells remain silent because of the increased endocannabinoid tone around them [11] . This previous finding either supports the theory of M1-stimulated endocannabinoid release or raises the possibility that there is an increased acetylcholine tone around these neurons at the same time.
The hyperpolarization by carbachol does not completely overlap with the hyperpolarization caused by ACEA as the cells hyperpolarized by carbachol respond in a heterogeneous manner to ACEA. In accordance with the hypothesis of the M1-mediated endocannabinoid release, one can assume that the neurons hyperpolarized by carbachol have M2 or M4 receptors, and activation of these receptors might overwrite the heterogeneous effect of endocannabinoids synthesized in an M1-dependent manner. As a further possibility, neurons expressing different muscarinic receptors can express different mGluRs, which can also explain our findings.
Conclusion
To summarize our findings, muscarinic and CB1 receptors have similar effects on the same neuronal populations. Neurons depolarized or not affected by the muscarinic agonist carbachol responded to the CB1 receptor agonist ACEA in the same manner, whereas neurons hyperpolarized by carbachol were not always hyperpolarized by ACEA, but depolarization and the lack of response were also observed. This finding represents a similar overlap of neuromodulatory mechanisms of the PPN as it was shown with other substances, indicating that common neuromodulatory pathways might exist in the PPN.
